The growing threat of penicillin-resistant Streptococcus pneumoniae

Infectious Diseases in Clinical Practice

Volumn 6, Issue SUPPL. 2, 1997, Pages

  Murray, Barbara E ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BETA LACTAM ANTIBIOTIC; CEFEPIME; CEFOTAXIME; CEFTRIAXONE; CEFUROXIME; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; IMIPENEM; LEVOFLOXACIN; OFLOXACIN; OXACILLIN; PENICILLIN G; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; DNA TRANSFER; MUTATION; PENICILLIN RESISTANCE; PLASMID; REVIEW; SEROTYPE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

EID: 0030687908     PISSN: 10569103     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019048-199711002-00001     Document Type: Review

References (41)

1. Jernigan DB, Cetron MS, Breiman RF. Defining the public health impact of drug-resistant Streptococcus pneumoniae: report of a working group. MMWR 1996;45;1-15.
2. Woodhead MA, Macfarlane JT, McCracken JS, Rose DH, Finch RG. Prospective study of the aetiology and outcome of pneumonia in the community. Lancet 1987;1: 671-4.
3. Fass RJ. Outpatient treatment of lower respiratory tract infections. Infect Dis Clin Pract 1994;3(3 Suppl):138S-44S.
4. Bartlett JG, Mundy LM. Community-acquired pneumonia. N Engl J Med 995;333:1618-24.
5. Caputo GM, Appelbaum PC, Liu HH. Infections due to penicillin-resistant pneumococci: clinical, epidemiologic, and microbiologic features. Arch Intern Med 1993;153: 1301-7.
6. Klugman KP. Pneumococcal resistance to antibiotics. Clin Microbiol Rev 990;3:171-96.
7. Duchin JS, Breiman RF, Diamond A, et al. High prevalence of multidrug-resistant Streptococcus pneumoniae among children in a rural Kentucky community. Pediatr Infect Dis J 1995;14:745-50
8. CDC Prevalence of penicillin-resistant Streptococcus pneumoniae - Connecticut, 1992-1993. MMWR 1994;43: 216-7.
9. Hofmann J, Cetron MS, Farley MM, et al. The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. N Engl J Med 1995,333:481-6.
10. Doern GV, Brueggemann A, Holley HPJ, Rauch AM. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: Results of a 30-center national surveillance study. Antimicrob Agents Chemother 1996;40:1208-13.
11. Block SL, Harrison CJ, Hedrick JA, et al. Penicillin-resistant Streptococcus pneumoniae in acute otitis media: risk factors, susceptibility patterns, and antimicrobial management. Pediatr Infect Dis J 1995;14:751-9.
12. Holmberg SD, Solomon SL, Blake PA. Health and economic impacts of antimicrobial resistance. Rev Infect Dis 1987,9:1065-75.
13. Phelps CE. Bug/drug resistance: sometimes less is more. Med Care 1989,27:194-203.
14. Kiska DL, Kerr A, Jones MC, et al. Comparison of antimicrobial susceptibility methods for detection of penicillin-resistant Streptococcus pneumoniae. J Clin Microbiol 1995;33:229-32.
15. Jacobs MR, Bajaksouzian S, Appelbaum PC, et al. Evaluation of the E-test for susceptibility testing of pneumococci. Diagn Microbiol Infect Dis 1992;15:473-8.
16. Murray BE. Antibiotic resistance. Adv Intern Med 1997; 42:339-67.
17. Chapalain JC, Dusseau JY, Perrier-Gras-Claude JD, et al. Effect of rifampicin chemo-prophylaxis on the aerobic bacterial flora of the oropharynx. J Antimicrob Chemother 1994;33:151-5.
18. Jacoby GA, Medeiros AA. New mechanisms of bacterial resistance to antimicrobial agents. N Engl J Med 1991;324: 601-12.
19. Murray BE. New aspects of antimicrobial resistance and the resulting therapeutic dilemmas. J Infect Dis 1991;163: 1185-94.
20. Dowson CG, Hutchison A, Brannigan JA, et al. Horizontal transfer of penicillin-binding protein genes in penicillin-resistant clinical isolates of Streptococcus pneumoniae. Proc Nad Acad Sci USA 1989;86:8842-6.
21. Gold HS, Moellering RCJ. Antimicrobial-drug resistance. N Engl J Med 1996;335:1445-53.
22. Stanek RJ, Mufson MA. Emergence of penicillin-resistant invasive pneumococci in a single American community. Am J Med Sci 1995;310:150-5.
23. Nava JM, Bella F, Garau J, et al. Predictive factors for invasive disease due to penicillin-resistant Streptococcus pneumoniae: a population-based study. Clin Infect Dis 1994;19:884-90.
24. Musher DM. Streptococcus pneumoniae. In: Mandell GL, Dolin R, Bennett JE, editors. Principles and practice of infectious diseases. 4th ed. New York: Churchill Livingstone; 1995 p. 1811-26
25. Chesney PJ. The escalating problem of antimicrobial resistance in Streptococcus pneumoniae. Am J Dis Child 1992;146:912-16.
26. Kaplan IR. Comparison of the response to antimicrobial therapy of penicillin-resistant and penicillin-susceptible pneumococcal disease. Pediatr Infect Dis J 1995;14:890.
27. Tan TQ, Schutze GE, Mason EOJ, Kaplan SL. Antibiotic therapy and acute outcome of meningitis due to Strepto-coccus pneumoniae considered intermediate to broad-spectrum cephalosporins. Antimicrob Agents Chemother 1994;38:918-23.
28. Butler JC, Hofmann J, Cetron MS, Elliott JA, Facklam RR, Breiman RF, Pneumococcal Sentinel Surveillance Working Group. The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: an update from the Centers for Disease Control and Prevention's Pneumococcal Sentinel Surveillance System. J Infect Dis 1996;174:986-93.
29. Gehanno P, Lenoir G, Berche P. In vivo correlates for Streptococcus pneumoniae penicillin resistance in acute otitis media. Antimcrob Agents Chemother 1995;39:271-2.
30. Bradley JS, Connor JD. Ceftriaxone failure in meningitis caused by Streptococcus pneumoniae with reduced sus-ceptibility to β-lactam antibiotics. Pediatr Infect Dis J 1991;10:871-3.
31. Boken DJ, Chartrand SA, Goering RV, Kruger R. Harrison CJ. Colonization with penicillin-resistant Streptococcus pneumoniae in a child-care center. Pediatr Infect Dis J 1995;14:879-84.
32. Haglund LA, Istre GR, Pickett DA, Welch DF, Fine DP. Pneumococcus Study Group. Invasive pneumococcal disease in central Oklahoma: emergence of high-level penicillin resistance and multiple antibiotic resistance. J Infect Dis 1993;168:1532-6.
33. McGowanJE, Metchock BG. Penicillin-resistant pneumococci - an emerging threat to successful therapy. J Hosp Infect 1995;30(Suppl):472S-82S.
34. Kam KM, Luey KY, Fung SM, Yiu PP, Harden TJ, Cheung MM. Emergence of multiple-antibiotic-resistant Streptococcus pneumoniae in Hong Kong. Antimicrob Agents Chemother 1995;39:2667-70.
35. Dholakia N, Rolston KM, Ho DH, LeBlanc B, Bodey GP. Susceptibilities of bacterial isolates from patients with cancer to levofloxacin and other quinolones. Antimicrob Agents Chemother 1994;38:848-52.
36. Eliopoulos GM, Wennersten CB, Moellering RCJ. Comparative in vitro activity of levofloxacin and ofloxacin against gram-positive bacteria. Diagn Microbiol Infect Dis 1996;25:35-41.
37. Plouffe JF, Franklin County Pneumonia Study Group. Levofloxacin in vitro activity against bacteremic isolates of Streptococcus pneumoniae. Diagn Microbiol Infect Dis 1996;25:43-5.
38. Azoulay-Dupuis E, Vallee E, Veber B, Bedos JP, Bauchet J, Pocidalo JJ. In vivo efficacy of a new fluoroquinolone, sparfloxacin, against penicillin-susceptible and resistant and multiresistant strains of Streptococcuspneumoniae in a mouse model of pneumonia. Antimicrob Agents Chemother 1992;36:2698-2703.
39. Barry AL, Brown SD, Novick WJ. In vitro activities of cefotaxime, ceftriaxone, ceftazidime, cefpirome, and penicillin against Streptococcus pneumoniae isolates. Antimicrob Agents Chemother 1995;39:2193-6.
40. Butler JC, Breiman RF, Campbell JF, Lipman HB, Broome CV, Facklam RR. Polysaccharide pneumococcal vaccine efficacy: an evaluation of current recommendations. JAMA 1993;270:1826-31.
41. Shapiro ED, Berg AT, Austrian R, et al. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med 1991,325:1453-60.